3-Fluoro-4-(piperidin-1-ylmethyl)phenylboronic acid, 98+%, 5g

N-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 100mg

5-BROMO-3-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 250mg

(1,4-Dioxan-2-yl)methanol, 95.0%, 1g

2-(1-Cyclopentenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)1g

Filtres à membrane ester mixte de nitrate de cellulose 0,65 µm, 50 mm, 100 Pièce(s)

Creuset de fusion ROTILABO®, 50 ml, 1,5 mm, 1 pièce

1,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 250mg

5-(Propan-2-ylidene)cyclopenta-1,3-diene, 95.0%, 5g

4-chloro-6-(4-chlorophenyl)pyrimidine, 95.0%, 2.5g

Bekanamycin, 98%, 100mg

Kit d'essai Spectra/Por® Biotech CE, 100–500 dalton(s), 1 pièce(s)

4-Pentenyl Acetate>98.0%(GC)500mL